Aquesys Acquired By Allergan In $300M Deal

Aliso Viejo-based Aquesys, which was developing medical devices for treating glaucoma, has been acquired by Allergan for $300M in cash upfront plus additional payments based on milestones. Aquesys develops ocular implants which reduce intraocular pressure (IOP) associated with glaucoma. Aquesys is venture backed by Accuitive Medical Ventures, The Carlyle Group, Longitude Capital, Rho Ventures, and SV Life Sciences, and was headed by Ron Bache. The company had raised around $97.5M in funding in total. Allergan said the deal requires a waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.